(Q44163654)

30 November 2017

title

Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation (English)

1 reference

30 November 2017

Ivan Berlin

1

1 reference

30 November 2017

Henri-Jean Aubin

2

1 reference

30 November 2017

Anne-Marie Pedarriosse

3

1 reference

30 November 2017

Alexis Rames

4

1 reference

30 November 2017

Sylvie Lancrenon

5

1 reference

30 November 2017

Gilbert Lagrue

6

1 reference

30 November 2017

Lazabemide in Smoking Cessation Study Investigators

7

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

97

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

1347-1354

1 reference

Monoamine oxidases and tobacco smoking

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Inhibition of monoamine oxidase B in the brains of smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Neuropharmacology. Psychoactive smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Effects of selegiline (L-deprenyl) during smoking and short-term abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Errors in using tobacco withdrawal scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Cue exposure treatment for smoking relapse prevention: a controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

A randomized trial of nortriptyline for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

How effective is nicotine replacement therapy in helping people to stop smoking?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

Irreversible inhibition of monoamine oxidase by some components of cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00258.X

10.1046/J.1360-0443.2002.00258.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference